Yes, some gabapentin side effects can support an individual injury claim, but there is no open class settlement paying all users. Cases alleging lasting neurocognitive decline are being consolidated in a Philadelphia mass-tort program, not a federal class action. Gabapentin is a prescription antiseizure drug sold as Neurontin and often prescribed for nerve pain. Readers asking about compensation need to match a specific injury, timing, and proof of use to what courts are now accepting.
Official resources:
- Read the official guidance from NIH — Use this primary source to verify the official guidance.
- Read the official guidance from FDA — Use this primary source to verify the official guidance.
Table of Contents
- Which injuries are part of current claims?
- What do the official warnings already say?
- Why does off-label promotion still come up?
- What should you collect before calling a lawyer?
Which injuries are part of current claims?
The Philadelphia program consolidates dozens of products-liability cases alleging gabapentinoids caused neurocognitive decline, according to The Legal Intelligencer in fall 2026. The report describes a mass-tort structure for individual cases, with no federal multidistrict litigation reported. That focus matters because not every unpleasant side effect is a lawsuit injury.
Short-term dizziness, sleepiness, swelling, or nausea may support a medical-care discussion, but current litigation centers on lasting cognitive harm. A 2025 study often mentioned in these cases followed 26,416 chronic low-back-pain patients. Patients with six or more gabapentin prescriptions had 29% higher dementia incidence and 85% higher mild cognitive impairment incidence within 10 years, according to Eghrari and colleagues in the BMJ journal analysis.
What do the official warnings already say?
The FDA-approved label covers only postherpetic neuralgia in adults and add-on treatment for partial-onset seizures in patients age 3 and older, according to the current DailyMed drug label. Many nerve-pain prescriptions are therefore outside those two listed uses. The U.S. Food and Drug Administration warned on Dec.
19, 2019 that gabapentin and pregabalin can cause serious breathing difficulty. Higher-risk patients include older adults, people with COPD, and people taking opioids or other brain-slowing drugs, according to the FDA safety announcement. The approved label also warns that antiseizure drugs including gabapentin raise the risk of suicidal thoughts and behavior. Patients, families, and prescribers are told to watch for mood changes, agitation, and self-harm thoughts.
Why does off-label promotion still come up?
In 2004, Warner-Lambert agreed to plead guilty and pay over $430 million for illegally promoting Neurontin for unapproved uses, according to the U.S. Department of Justice. Those uses included pain, bipolar disorder, migraine, and ALS.
That history does not automatically qualify a present-day patient for payment. It can matter in lawsuits arguing that wider nerve-pain use grew through improper marketing rather than FDA review. For current patients, the stronger question is warning and monitoring. A breathing crisis while combining gabapentin with opioids, or suicide-related harm without proper warning and follow-up, raises different proof issues than later memory loss.
What should you collect before calling a lawyer?
Most firms review these cases individually, so records decide whether a review moves forward. Gather complete pharmacy records, prescribing notes, diagnosis history, and dates of first symptoms.
Do not stop, change, or restart gabapentin to preserve a claim. Sudden changes can cause seizures and other harm, so discuss risks and tapering only with the prescriber. Keep copies of everything sent to a lawyer or claims administrator.
- Pharmacy printout showing gabapentin doses, refills, and dates taken
- Medical records for pain, seizures, sleep apnea, COPD, depression, and opioid use
- Hospital, breathing-treatment, psychiatric, or neurology records tied to the injury
- Cognitive testing, dementia or memory-loss diagnoses, work limitations, and caregiver notes
- Drug cartons, receipts, insurance claims, and a timeline of prescribers